Development of a new travellers’ diarrhoea clinical severity classification and its utility in confirming rifamycin-SV efficacy

Bacterial travellers’ diarrhoea: A narrative review of literature published over the past 10 years

(2022) Rogelio López-Vélez et al.   Travel Medicine and Infectious Disease

Travel-associated multidrug-resistant organism acquisition and risk factors among US military personnel

(2021) Gregory Buchek et al.   JOURNAL OF TRAVEL MEDICINE

Antimicrobial-resistant bacteria in international travelers

(2021) Sushmita Sridhar et al.   CURRENT OPINION IN INFECTIOUS DISEASES

What’s new in travelers’ diarrhea: Updates on epidemiology, diagnostics, treatment, and long-term consequences

(2021) Audrey A Adler et al.   JOURNAL OF TRAVEL MEDICINE

A disease severity scale for the evaluation of vaccine and other preventive or therapeutic interventions for travellers’ diarrhoea

(2021) Nicole Maier et al.   JOURNAL OF TRAVEL MEDICINE

Travel, Diarrhea, Antibiotics, Antimicrobial Resistance and Practice Guidelines—a Holistic Approach to a Health Conundrum

(2020) Mark S. Riddle   Current Infectious Disease Reports

Global Geographic Trends in Antimicrobial Resistance: The Role of International Travel

(2019) Isabel Frost et al.   JOURNAL OF TRAVEL MEDICINE

Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score

(2018) Chad K. Porter et al.   PLoS One

An Evidenced-Based Scale of Disease Severity following Human Challenge with Enteroxigenic Escherichia coli

(2016) Chad K. Porter et al.   PLoS One

Antimicrobials Increase Travelers' Risk of Colonization by Extended-Spectrum Betalactamase-Producing Enterobacteriaceae

(2015) A. Kantele et al.   CLINICAL INFECTIOUS DISEASES

Traveler’s Diarrhea

(2015) Robert Steffen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A Systematic Review of the Measurement of Endoscopic Healing in Ulcerative Colitis Clinical Trials

(2014) Mark A. Samaan et al.   INFLAMMATORY BOWEL DISEASES

Targeting of Rifamycin SV to the Colon for Treatment of Travelers' Diarrhea: A Randomized, Double‐Blind, Placebo‐Controlled Phase 3 Study

(2014) Herbert L. DuPont et al.   JOURNAL OF TRAVEL MEDICINE